Clinical Practice Updates: Help your patients with nonalcoholic fatty liver disease (NAFLD) lose weight

In episode three of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by co-host Dr. Lisa Byers, an assistant professor within the hospital medicine department at the University of Rochester School of Medicine. They discuss the inadequate practices for HE management in the inpatient setting. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

Welcome to episode one of our six-part series on hepatic encephalopathy (HE), a major complication and a frequent cause of both initial hospitalization and readmission in cirrhotic patients. In this episode, Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Robert Rahimi, a board-certified physician in transplant hepatology, gastroenterology and internal medicine practicing at Baylor University Medical Center, as well as an associate professor of medicine at Texas A&M. They will discuss current and emerging treatment modalities for HE. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

In episode two of our six-part series on hepatic encephalopathy (HE), Dr. Lisa Byers, a hospitalist and assistant professor in hospital medicine at the University of Rochester Medical Center, is joined by Dr. Elliot Tapper, an associate professor in the division of gastroenterology and hepatology at University of Michigan, the director of the Michigan cirrhosis program and the editor in chief of Hepatology Communications. They discuss the changing epidemiology of cirrhosis and hepatic encephalopathy. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC.  

In our final episode on hepatic encephalopathy (HE), Dr. Lisa Byers, a hospitalist and assistant professor in hospital medicine at the University of Rochester Medical, is joined by co-host Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine. They delve into the article "Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy," authored by Drs. Jasmohan S. Bajaj, Angela Gentilly, James Wade, and Michael Godschalk, and published in Clinical Gastroenterology and Hepatology. Together, they explore best practices for staying current with the evolving literature and research on these conditions and discuss strategies for integrating new insights into daily clinical practice. To claim CME for listening, please visit AGA University at agau.gastro.org. This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

In episode five of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Craig Rosenstengle, a fellow at Baylor University Medical Center in the combined gastroenterology and transplant hepatology pathway. They will discuss hepatic encephalopathy and strategies to prevent readmissions from inadequate transitions of care. To claim CME for listening, please visit AGA University at agau.gastro.org This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

In episode four of our six-part series on hepatic encephalopathy (HE), Dr. Robert Brown, chief of the division of gastroenterology and hepatology at Weill Cornell Medicine, is joined by Dr. Alpesh Amin, a professor of medicine at the University of California, Irvine ( UCI), the endowed chair of the UCI School of Medicine Department of Medicine, and the executive director of UCI's Hospitalist Program. They discuss missed diagnosis in the inpatient setting. To claim CME for listening, please visit AGA University at agau.gastro.org. This independent educational program was developed in collaboration with the Society for Hospital Medicine and supported by an independent medical education grant from Salix Pharmaceuticals, a division of Bausch Health US LLC. 

Welcome to a special two-episode series: Do You See What I-SEE? A Practical How-To for Using Eosinophilic Esophagitis Severity Tools. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured in both AGA’s Inside Scope podcast channel as well as PIK’s Morning Commute podcast channel. Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Drs. Evan Dellon and Nirmala Gonsalves discuss the roles of different assessment tools in clinical practice, how they traditionally evaluate disease severity, and why the EoE community saw a need for something like the I-SEE Clinical Index. Supported by educational grants from Bristol Myers Squibb and Takeda Pharmaceuticals U.S.A., Inc. Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Welcome to a special two-episode series: Do You See What I-SEE? A Practical How-To for Using Eosinophilic Esophagitis Severity Tools. These episodes have been developed in partnership between American Gastroenterological Association (AGA) and Projects In Knowledge (PIK) Powered By Kaplan and are featured in both AGA’s Inside Scope podcast channel as well as PIK’s Morning Commute podcast channel. Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Dr. Evan Dellon and Dr. Emily McGowan discuss the features measured by the I-SEE clinical index and its role in evaluating EoE severity, as well as evidence behind the ongoing validation of this tool and implications for future use. Supported by educational grants from Bristol Myers Squibb and Takeda Pharmaceuticals U.S.A., Inc. Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. Originally released as a bonus episode in January 2023, this episode shares key insights from the AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease (published in the February 2021 issue of Gastroenterology). This episode is hosted by Dr. Jana Al Hashash, member of the AGA Clinical Practice Update Committee. She is joined by: -Dr. Heather Patton, NAFLD expert and past member of the AGA Clinical Practice Update Committee -Dr. Joseph K. Lim, past chair of the AGA Clinical Practice Update Committee and co-author of this CPU -Dr. Zobair M Younossi, co-author of this CPU To access the full expert review, visit www.gastro.org/CPU.

Enhance your patient care skills with this season covering select AGA Clinical Practice Updates. This episode shares key insights from the AGA Clinical Practice Update: Diet and Nutritional Therapies (published in the March 2024 issue of Gastroenterology). This episode is hosted by Dr. Jana Al Hashash, chair of the AGA Clinical Practice Update Committee. She is joined by authors -Dr. David Binion, professor of medicine and co-director of the IBD Center, director of nutrition support service, at UPMC Presbyterian Hospital and University of Pittsburgh; co-author of CPU -Dr. James Lewis, professor of medicine and epidemiology at the Perelman School of Medicine at the University of Pennsylvania ; co-author of CPU -Ms. Kelly Issokson, registered dietitian and clinical coordinator of digestive diseases at Cedars-Sinai in Los Angeles To access the full Clinical Practice Update, visit www.gastro.org/CPU.